Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 488,543 | 64,867 | 43,401 | 0 | 0 |
| Cost of Goods | 15,659 | 11,733 | N/A | N/A | N/A |
| Gross Profit | 472,884 | 53,134 | 43,401 | N/A | N/A |
| Operating Expenses | 435,469 | 284,683 | 163,871 | 83,512 | 61,438 |
| Operating Income | 38,074 | -230,816 | -120,470 | -83,512 | -61,438 |
| Interest Expense | 0 | 0 | 1,731 | 0 | 0 |
| Other Income | 4,890 | 5,442 | 1,917 | 295 | 16 |
| Pre-tax Income | 42,964 | -225,374 | -120,284 | -83,217 | -61,422 |
| Income Tax | 2,192 | 447 | 1,275 | N/A | N/A |
| Net Income Continuous | 40,772 | -225,821 | -121,559 | -83,217 | -61,422 |
| Net Income | $40,772 | $-225,821 | $-121,559 | $-83,217 | $-61,422 |
| EPS Basic Total Ops | 0.44 | -2.78 | -4.02 | N/A | N/A |
| EPS Basic Continuous Ops | 0.44 | -2.78 | -4.02 | N/A | N/A |
| EPS Diluted Total Ops | 0.43 | -2.78 | -4.02 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.43 | -2.78 | -4.02 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.48 | -2.74 | -2.24 | N/A | N/A |
| EBITDA(a) | $45,230 | $-227,662 | $-119,743 | $-83,211 | $-61,301 |